To further investigate whether overexpression of TP53 mutations increases cytotoxicity in lung cancer cells treated with simvastatin, we transiently transfected WT TP53 and R248W mutants into p53 null H1299 cells and then measured cell viability under simvastatin treatment (Fig. 3E). The gene discussed is TP53; the disease is lung carcinoma.